The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Carfilzomib and dexamethasone (Kd56) vs bortezomib and dexamethasone (Vd) in relapsed or refractory multiple myeloma (RRMM): Updated overall survival (OS), safety, and subgroup analysis of ENDEAVOR.
 
Robert Z. Orlowski
Consulting or Advisory Role - Celgene; FORMA Therapeutics; Incyte; Janssen; Takeda
Research Funding - Amgen; BioTheryX
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Heinz Ludwig
Consulting or Advisory Role - Amgen; Janssen; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen; Takeda
 
Albert Oriol Rocafiguera
No Relationships to Disclose
 
Wee Joo Chng
Honoraria - Amgen; Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - Celgene; Janssen; Merck; Novartis; Roche
 
Hartmut Goldschmidt
Honoraria - Art tempi; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen-Cilag; Novartis
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi; Takeda (Inst)
Speakers' Bureau - Art tempi; Bristol-Myers Squibb; Celgene; Chugai Pharma Europe; Janssen; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
 
Zhao Yang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Amy Kimball
No Relationships to Disclose
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho